US Patent Issued to VACDIAGN BIOTECHNOLOGY on Dec. 30 for "Recombinant viral vector, immunogenic composition comprising same, and uses" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,309, issued on Dec. 30, was assigned to VACDIAGN BIOTECHNOLOGY Co. LTD. (Jiangsu, China).

"Recombinant viral vector, immunogenic composition comprising same, and uses" was invented by Jianqing Xu (Jiangsu, China), Yang Huang (Jiangsu, China) and Jiahao Sun (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A recombinant viral vector, an immunogenic composition comprising the same, and uses. The recombinant viral vector comprises a polynucleotide encoding a cytokine, the cytokine being one or more selected from IL-7, IL-15, IL-21 or GM-CSF. The recombinant viral vector is useful in preparing an antitumor vaccine."

The patent was filed on...